vs

Side-by-side financial comparison of Frontdoor, Inc. (FTDR) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $432.0M, roughly 1.1× Frontdoor, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 0.2%, a 6.6% gap on every dollar of revenue. On growth, Frontdoor, Inc. posted the faster year-over-year revenue change (12.8% vs -1.7%). Over the past eight quarters, Frontdoor, Inc.'s revenue compounded faster (6.9% CAGR vs -0.1%).

Frontdoor, Inc. operates a leading U.S.-focused home services and protection platform. It offers customizable home warranty plans covering repairs and replacements for household appliances, HVAC, plumbing, and electrical systems, plus on-demand access to a network of pre-vetted local service professionals for residential maintenance and repairs.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

FTDR vs MD — Head-to-Head

Bigger by revenue
MD
MD
1.1× larger
MD
$493.8M
$432.0M
FTDR
Growing faster (revenue YoY)
FTDR
FTDR
+14.5% gap
FTDR
12.8%
-1.7%
MD
Higher net margin
MD
MD
6.6% more per $
MD
6.8%
0.2%
FTDR
Faster 2-yr revenue CAGR
FTDR
FTDR
Annualised
FTDR
6.9%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FTDR
FTDR
MD
MD
Revenue
$432.0M
$493.8M
Net Profit
$1.0M
$33.7M
Gross Margin
49.3%
Operating Margin
0.5%
9.9%
Net Margin
0.2%
6.8%
Revenue YoY
12.8%
-1.7%
Net Profit YoY
-88.9%
10.5%
EPS (diluted)
$0.03
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FTDR
FTDR
MD
MD
Q4 25
$432.0M
$493.8M
Q3 25
$618.0M
$492.9M
Q2 25
$617.0M
$468.8M
Q1 25
$426.0M
$458.4M
Q4 24
$383.0M
$502.4M
Q3 24
$540.0M
$511.2M
Q2 24
$542.0M
$504.3M
Q1 24
$378.0M
$495.1M
Net Profit
FTDR
FTDR
MD
MD
Q4 25
$1.0M
$33.7M
Q3 25
$106.0M
$71.7M
Q2 25
$111.0M
$39.3M
Q1 25
$37.0M
$20.7M
Q4 24
$9.0M
$30.5M
Q3 24
$100.0M
$19.4M
Q2 24
$92.0M
$-153.0M
Q1 24
$34.0M
$4.0M
Gross Margin
FTDR
FTDR
MD
MD
Q4 25
49.3%
Q3 25
57.1%
Q2 25
57.7%
Q1 25
55.2%
Q4 24
48.0%
Q3 24
56.7%
Q2 24
56.5%
Q1 24
51.6%
Operating Margin
FTDR
FTDR
MD
MD
Q4 25
0.5%
9.9%
Q3 25
23.0%
13.8%
Q2 25
23.7%
12.8%
Q1 25
11.3%
7.0%
Q4 24
1.6%
7.8%
Q3 24
24.8%
6.6%
Q2 24
22.9%
-31.3%
Q1 24
11.9%
3.2%
Net Margin
FTDR
FTDR
MD
MD
Q4 25
0.2%
6.8%
Q3 25
17.2%
14.5%
Q2 25
18.0%
8.4%
Q1 25
8.7%
4.5%
Q4 24
2.3%
6.1%
Q3 24
18.5%
3.8%
Q2 24
17.0%
-30.3%
Q1 24
9.0%
0.8%
EPS (diluted)
FTDR
FTDR
MD
MD
Q4 25
$0.03
$0.40
Q3 25
$1.42
$0.84
Q2 25
$1.48
$0.46
Q1 25
$0.49
$0.24
Q4 24
$0.10
$0.37
Q3 24
$1.30
$0.23
Q2 24
$1.18
$-1.84
Q1 24
$0.43
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FTDR
FTDR
MD
MD
Cash + ST InvestmentsLiquidity on hand
$566.0M
$375.2M
Total DebtLower is stronger
$1.1B
$570.5M
Stockholders' EquityBook value
$242.0M
$865.9M
Total Assets
$2.1B
$2.2B
Debt / EquityLower = less leverage
4.73×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FTDR
FTDR
MD
MD
Q4 25
$566.0M
$375.2M
Q3 25
$563.0M
$340.1M
Q2 25
$562.0M
$224.7M
Q1 25
$506.0M
$99.0M
Q4 24
$436.0M
$229.9M
Q3 24
$375.0M
$103.8M
Q2 24
$419.0M
$19.4M
Q1 24
$378.0M
$8.0M
Total Debt
FTDR
FTDR
MD
MD
Q4 25
$1.1B
$570.5M
Q3 25
$1.2B
$577.2M
Q2 25
$1.2B
$583.9M
Q1 25
$1.2B
$590.5M
Q4 24
$1.2B
$597.1M
Q3 24
$565.0M
Q2 24
$569.0M
Q1 24
$573.0M
Stockholders' Equity
FTDR
FTDR
MD
MD
Q4 25
$242.0M
$865.9M
Q3 25
$316.0M
$890.7M
Q2 25
$254.0M
$833.8M
Q1 25
$198.0M
$789.2M
Q4 24
$239.0M
$764.9M
Q3 24
$261.0M
$732.5M
Q2 24
$214.0M
$706.5M
Q1 24
$162.0M
$856.2M
Total Assets
FTDR
FTDR
MD
MD
Q4 25
$2.1B
$2.2B
Q3 25
$2.2B
$2.2B
Q2 25
$2.2B
$2.1B
Q1 25
$2.1B
$2.0B
Q4 24
$2.1B
$2.2B
Q3 24
$1.2B
$2.1B
Q2 24
$1.2B
$2.0B
Q1 24
$1.1B
$2.2B
Debt / Equity
FTDR
FTDR
MD
MD
Q4 25
4.73×
0.66×
Q3 25
3.64×
0.65×
Q2 25
4.56×
0.70×
Q1 25
5.88×
0.75×
Q4 24
4.90×
0.78×
Q3 24
2.16×
Q2 24
2.66×
Q1 24
3.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FTDR
FTDR
MD
MD
Operating Cash FlowLast quarter
$101.0M
$114.1M
Free Cash FlowOCF − Capex
$95.0M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
101.00×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$390.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FTDR
FTDR
MD
MD
Q4 25
$101.0M
$114.1M
Q3 25
$64.0M
$137.3M
Q2 25
$127.0M
$137.2M
Q1 25
$124.0M
$-117.5M
Q4 24
$58.0M
$133.0M
Q3 24
$25.0M
$91.8M
Q2 24
$103.0M
$107.0M
Q1 24
$84.0M
$-125.2M
Free Cash Flow
FTDR
FTDR
MD
MD
Q4 25
$95.0M
Q3 25
$58.0M
Q2 25
$120.0M
Q1 25
$117.0M
Q4 24
$50.0M
Q3 24
$16.0M
Q2 24
$91.0M
Q1 24
$74.0M
FCF Margin
FTDR
FTDR
MD
MD
Q4 25
22.0%
Q3 25
9.4%
Q2 25
19.4%
Q1 25
27.5%
Q4 24
13.1%
Q3 24
3.0%
Q2 24
16.8%
Q1 24
19.6%
Capex Intensity
FTDR
FTDR
MD
MD
Q4 25
1.4%
Q3 25
1.0%
Q2 25
1.1%
Q1 25
1.6%
Q4 24
2.1%
Q3 24
1.7%
Q2 24
2.2%
Q1 24
2.6%
Cash Conversion
FTDR
FTDR
MD
MD
Q4 25
101.00×
3.39×
Q3 25
0.60×
1.91×
Q2 25
1.14×
3.49×
Q1 25
3.35×
-5.66×
Q4 24
6.44×
4.36×
Q3 24
0.25×
4.72×
Q2 24
1.12×
Q1 24
2.47×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FTDR
FTDR

Renewals$332.0M77%
Other$43.0M10%
Direct To Consumer Home Service Plan Contracts$30.0M7%
Real Estate Home Service Plan Contracts$27.0M6%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons